Additionally, ERK5 inhibition reduced the macrophage-mediated clearance of apoptotic tumor cells, leading to the release of tumor antigens and converting a cold tumor microenvironment into a hot one, thus enhancing immune recognition and attack on tumors (136). The gene discussed is MAPK7; the disease is neoplasm.